Related Experiment Video
Updated: Aug 12, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Next-generation sequencing and molecular therapy
Cienne Morton1, Debashis Sarker2, Paul Ross3
1Medical Oncology Department, Guy's and St Thomas' NHS Foundation Trust, London, UK Cienne.morton@gstt.nhs.uk.
Abstract:
Cancers contain a plethora of mutations, few of which are critical to maintaining a state of malignancy. With our ever-expanding understanding of the genomic complexity of cancer, potentially actionable biomarkers whose inhibition could cripple cancer growth are increasingly being elucidated. Modern cancer drug development has largely switched from cytotoxic agents to targeted therapies and immunotherapy, with noteworthy success in several cancer types including non-small-cell lung cancer (NSCLC), breast cancer and melanoma. Next-generation sequencing offers high-throughput, widescale genomic interrogation in a far more efficient and affordable manner than previous sequencing methods. This facilitates detection of potentially actionable mutations and fusions for individual patients and contributes to the identification of novel predictive and prognostic biomarkers in a population. Challenges in the technical aspects of biopsy and sequencing, interpretation, and development of targeted therapies against common genomic aberrations will need to be addressed for personalised medicine to become a reality for more patients with cancer.
Insights
Identifying critical cancer mutations is key. Next-generation sequencing aids in finding actionable biomarkers for targeted therapies, advancing personalized cancer medicine.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Cancers possess numerous mutations, but only a few drive malignancy.
- Understanding cancer's genomic complexity reveals actionable biomarkers.
- Targeted therapies and immunotherapy show success in cancers like NSCLC, breast, and melanoma.
Purpose of the Study:
- To highlight the role of next-generation sequencing in identifying actionable cancer mutations.
- To discuss the shift towards targeted therapies and immunotherapy in cancer treatment.
- To outline challenges in achieving personalized medicine for more cancer patients.
Main Methods:
- Utilizing next-generation sequencing for high-throughput genomic interrogation.
- Analyzing genomic data to detect actionable mutations and fusions.
- Reviewing advancements in targeted therapy and immunotherapy development.
Main Results:
- Next-generation sequencing enables efficient and affordable genomic analysis.
- Detection of actionable mutations and fusions is facilitated for individual patients.
- Identification of novel predictive and prognostic biomarkers is enhanced.
Conclusions:
- Personalized medicine relies on identifying critical cancer mutations and developing targeted therapies.
- Next-generation sequencing is crucial for advancing personalized cancer care.
- Overcoming challenges in biopsy, sequencing, interpretation, and therapy development is essential for broader personalized medicine application.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Modern Molecular Taxonomy
Targeted Cancer Therapies
There are several types of targeted therapies against...
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...